Implications of the tumor immune microenvironment for staging and therapeutics
Janis M. TaubeDepartment of Dermatology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MDJérôme GalonINSERM, Laboratory of Integrative Cancer Immunology, Paris, FranceLynette M. ShollDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USAScott J. RodigDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USATricia R. CottrellDepartment of Pathology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USANicolás A. GiraldoDepartment of Dermatology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MDAlexander S. BarasDepartment of Pathology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USASanjay S. PatelDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USARobert A. AndersDepartment of Pathology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USADavid L. RimmDepartment of Pathology, Yale University School of Medicine, New Haven, CT, USAAshley Cimino‐MathewsDepartment of Oncology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USA
2017en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0